What Researchers Did
A clinician reported on a single 60-year-old woman with Chronic Inflammatory Response Syndrome (CIRS), a complex illness linked to mold toxin exposure, who underwent 40 low-pressure HBOT sessions (shallow dive) over 10 weeks.
What They Found
After 40 HBOT sessions, all 22 of the patient's symptoms resolved. Her visual contrast sensitivity score improved from 68% to 93% (normal is above 70%). Inflammatory biomarkers including TGF-β1 and MMP-9 dropped significantly. These improvements were noted incidentally, the HBOT was not originally prescribed for CIRS.
What This Means for Canadian Patients
For Canadians dealing with CIRS, a condition linked to mold exposure in water-damaged buildings, which can cause fatigue, brain fog, and multi-system symptoms, this case suggests HBOT may help, but a single patient report cannot be used to draw firm conclusions. It highlights an area where more research is needed.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a single-patient case report with no control condition, no blinding, and a pre/post comparison using different commercial labs, which limits the reliability of biomarker comparisons.